Why did Changshan Medicine lose money?

The increase in operating costs led to a decrease in gross profit margin. Changshan medicine is losing money, because the operating cost rises, resulting in a decline in gross profit margin. The full name of Changshan Medicine is Hebei Changshan Biochemical Pharmaceutical Co., Ltd., which was established on September 28, 2000. It mainly develops, produces and sells drugs for treating cardiovascular and cerebrovascular diseases, and its products are exported to Europe, America, CIS, Southeast Asia and other countries.